https://orcid.org/0000-0003-4346-8319
References
- Alharbi KS , AfzalO, AlmalkiWHet al. Nuclear factor-kappa B (NF-κB) inhibition as a therapeutic target for plant nutraceuticals in mitigating inflammatory lung diseases. Chem. Biol. Interact.354, 109842 (2022).
- Satija S , MehtaM, GuptaG, ChellappanDK, DuaK. Targeting interleukins in chronic airway diseases using advanced drug delivery. Future Med. Chem.12(20), 1805–1807 (2020).
- Prasher P , SharmaM, ChellappanDKet al. Advanced drug delivery systems targeting NF-κB in respiratory diseases. Future Med. Chem.13(13), 1087–1090 (2021).
- Chan Y , MehtaM, PaudelKRet al. Versatility of liquid crystalline nanoparticles in inflammatory lung diseases. Nanomedicine16(18), 1545–1548 (2021).
- Chellappan DK , HansbroPM, DuaKet al. Vesicular systems containing curcumin and their applications in respiratory disorders – a mini review. Pharm. Nanotechnol.5(4), 250–254 (2017).
- Chellappan DK , NgZY, WongJYet al. Immunological axis of curcumin-loaded vesicular drug delivery systems. Future Med. Chem.10(8), 839–844 (2018).
- Awasthi A , KumarB, GulatiMet al. Novel nanostructured lipid carriers co-loaded with mesalamine and curcumin: formulation, optimization and in vitro evaluation. Pharm. Res.39(11), 2817–2829 (2022).
- Sharma A , HawthorneS, JhaSKet al. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDA-MB231 human breast cancer cells. Nanomedicine16(20), 1763–1773 (2021).
- Zhong W , ZhangX, ZengY, LinD, WuJ. Recent applications and strategies in nanotechnology for lung diseases. Nano Res.14(7), 2067–2089 (2021).
- Wang W , ZhuR, XieQet al. Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int. J. Nanomedicine7, 3667–3677 (2012).
- Evans CE . Hypoxia-inducible factor signaling in inflammatory lung injury and repair. Cells11(2), 183 (2022).
- Alhusaini A , AlhumaidanS, AlmogrenR, AlsaifS, AlsultanE, HusseinI. Nano-curcumin protects against sodium nitrite–induced lung hypoxia through modulation of mitogen-activated protein kinases/c-Jun NH2-terminal kinase signaling pathway. Dose Response19(3), 15593258211033148 (2021).
- Mittal M , SiddiquiMR, TranK, ReddySP, MalikAB. Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal.20(7), 1126–1167 (2014).
- Yuan R , LiY, HanSet al. Fe–curcumin nanozyme-mediated reactive oxygen species scavenging and anti-inflammation for acute lung injury. ACS Cent. Sci.8(1), 10–21 (2022).
- Piao C , ZhuangC, KangM, OhJ, LeeM. Pulmonary delivery of curcumin-loaded glycyrrhizic acid nanoparticles for anti-inflammatory therapy. Biomater. Sci.10(23), 6698–6706 (2022).
- Yen F-L , TsaiM-H, YangC-Met al. Curcumin nanoparticles ameliorate ICAM-1 expression in TNF-α-treated lung epithelial cells through p47 phox and MAPKs/AP-1 pathways. PLOS ONE8(5), e63845 (2013).
- Valizadeh H , Abdolmohammadi-VahidS, DanshinaSet al. Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. Int. Immunopharmacol.89, 107088 (2020).
- Asadirad A , NashibiR, KhodadadiAet al. Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial. Phytother. Res.36(2), 1023–1031 (2022).
- Hassaniazad M , EftekharE, InchehsablaghBRet al. A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients. Phytother. Res.35(11), 6417–6427 (2021).
- Li Y , GuoC, ChenQet al. Improvement of pneumonia by curcumin-loaded bionanosystems based on Platycodon grandiflorum polysaccharides via calming cytokine storm. Int. J. Biol. Macromol.202, 691–706 (2022).